Total planned funding: $79,361,181
Clear active filters
Multi-lateral Agency
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Ethiopia | $21,027,360 |
South Africa | $8,781,700 |
Asia Regional Program | $8,259,665 |
Mozambique | $7,619,526 |
Ukraine | $5,663,021 |
Tanzania | $3,905,545 |
Eswatini | $3,375,650 |
Kenya | $2,999,680 |
Russia | $1,806,000 |
Uganda | $1,724,512 |
Rwanda | $1,610,274 |
Haiti | $1,500,000 |
Malawi | $1,500,000 |
Guyana | $1,430,000 |
Burma | $1,050,000 |
Côte d'Ivoire | $1,000,000 |
Zambia | $955,000 |
India | $850,000 |
Caribbean Region | $770,000 |
Namibia | $633,758 |
Nigeria | $589,080 |
Central America Region | $450,410 |
Papua New Guinea | $450,000 |
Botswana | $400,000 |
Central Asia Region | $325,000 |
Lesotho | $280,000 |
Cameroon | $255,000 |
Zimbabwe | $50,000 |
Vietnam | $50,000 |
Dominican Republic | $50,000 |
Organizational Types
Multi-lateral Agency | $79,361,181 |
Program Areas
Care | $33,556,870 |
Prevention | $18,979,709 |
Governance and Systems | $12,134,539 |
Treatment | $10,953,058 |
Testing | $3,737,005 |
Budget Codes
HBHC: Care: Adult Care and Support | $16,162,939 |
HKID: Care: Orphans and Vulnerable Children | $13,559,072 |
HTXS: Treatment: Adult Treatment | $10,126,352 |
OHSS: Health Systems Strengthening | $6,568,210 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $5,975,903 |
HVSI: Strategic Information | $4,644,848 |
HVOP: Sexual Prevention: Other Sexual Prevention | $4,242,581 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,955,280 |
HVCT: Testing: HIV Testing and Counseling | $3,737,005 |
HVTB: Care: TB/HIV | $3,192,104 |
HMBL: Biomedical Prevention: Blood Safety | $2,222,000 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $1,301,945 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $1,175,000 |
HLAB: Laboratory Infrastructure | $921,481 |
PDTX: Treatment: Pediatric Treatment | $821,706 |
PDCS: Care: Pediatric Care and Support | $642,755 |
HMIN: Biomedical Prevention: Injection Safety | $107,000 |
HTXD: Treatment: ARV Drugs | $5,000 |
Top Partner Programs
World Health Organization:
$16,542,047
View countries